Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1714027

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sipavibart
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution by the Parliamentary Under Secretary of State at the Department of Health and Social Care during the debate on Covid-19: Response and Excess Deaths on Thursday 18 April 2024, Official Report, column 537, whether she has had recent discussions with (a) NICE and (b) the MHRA on their progress on reaching a decision on whether to recommend the use of Evusheld 2 to prevent covid-19.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	23829
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>The Department meets with the National Institute of Health and Care Excellence (NICE) regularly to discuss a range of issues, including access to medicines. The NICE has formally started its appraisal of AZD-3152, also known as sipavibart and referred to as Evusheld 2, ahead of the Medicines and Healthcare products Regulatory Agency’s (MHRA) decision on whether it should be given a United Kingdom marketing authorisation, and expects to invite stakeholder submissions in April 2024. Timelines for both the NICE’s guidance and licensing depend on data from the SUPERNOVA trial being available. AstraZeneca intends to submit clinical data to the NICE and the MHRA at the same time, with the aim that both organisations are able to reach decisions as close together as possible. If AZD-3152 is recommended as clinically and cost effective by the NICE, the National Health Service in England will be under a statutory requirement to fund AZD-3152 for eligible patients, in line with the NICE’s recommendations.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 01/05/2024 08:57:40 answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope

1713829

registered interest
date	25/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the cost to NHS England has been of reimbursing GP practices for providing services to (a) non-UK and (b) non-registered UK citizens in each of the last three years for which information is available.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	23670
answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>General practices (GPs) are paid for providing essential services to all their patients via global sum payments, which are weighted to take patient needs into account. Therefore, there are no dedicated GP payments for providing services to non-United Kingdom or non-registered UK citizens, and the Department does not hold data on GP patient lists by nationality.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 30/04/2024 21:20:59 answering member 4117 label Biography information for Andrea Leadsom previous answer version 31584 answering member constituency South Northamptonshire answering member printed Andrea Leadsom answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1713579

registered interest
date	24/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Personal Records
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what evidence of (a) identity and (b) immigration status GPs require from patients seeking to access their services; and whether her Department provides guidance to GPs on ensuring that identification provided by those people is genuine.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	23367
answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>Patients have the legal right to choose a general practice (GP) that best suits their needs. An individual should not be refused registration or appointments because they do not have proof of address or personal identification. Patients do not need to provide proof of address or immigration status, identification, or a National Health Service number to register with a GP. The vast majority of migrants are required to pay the Immigration Health Surcharge when applying for a visa to stay in the United Kingdom for longer than six months.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 29/04/2024 16:10:48 answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1697875

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Dorset
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of the extra allocations of money made from the discharge fund to the (a) NHS and (b) local authorities in Dorset in the 2023-24 financial year on the (i) timeliness and (ii) effectiveness of the discharge of patients from NHS hospitals.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	19766
answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>The Government is investing an additional £600 million for 2023/24 and £1 billion for 2024/25, through the Discharge Fund, to support the National Health Service and local authorities in ensuring timely and effective discharge from hospital. As part of their allocations for 2023/24, NHS Dorset Integrated Care Board received £5.7 million, Bournemouth, Christchurch and Poole Council received £1.9 million, and Dorset Council received £1.7 million. There will be an independent evaluation of the Discharge Fund for 2023/24 and 2024/25.</p><p>Nationally, this funding has supported more people to be discharged more quickly with more appropriate support. The number of people discharged from hospital with packages of health and social care support increased by 10% between the end of February 2023 and the end of February 2024. Thanks to this improved patient flow hospitals have been able to admit and treat more patients during this period.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 28/03/2024 12:08:27 answering member 4527 label Biography information for Helen Whately previous answer version 26254 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
tabling member	242 label Biography information for Sir Christopher Chope

1697945

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tobacco and Vapes Bill
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that the Regulatory Policy Committee's revised opinion on the Tobacco and Vapes Bill is published by 16 April 2024.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	19767
answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. That is why we have introduced the Tobacco and Vapes Bill to create the first smokefree generation, and enable us to further crack down on youth vaping. The Tobacco and Vapes Bill is available at the following link:</p><p><a href="https://bills.parliament.uk/bills/3703" target="_blank">https://bills.parliament.uk/bills/3703</a></p><p>On 12 February 2024 the Regulatory Policy Committee (RPC) gave opinion on the Tobacco and Vapes Bill impact assessment and rated it green (fit for purpose). However, on 19 March 2024, ahead of the introduction of the bill, a revised version was sent to the RPC for comment. This included changes to reflect the inclusion of Northern Ireland in the bill, following the formation of a Northern Ireland Executive, and a power in the bill to enable the current notification system for nicotine vapes to also cover non-nicotine vapes and other consumer nicotine products, for instance nicotine pouches. The RPC have publicly stated that they welcome the resubmission of the revised impact assessment, and we expect a revised opinion to be issued shortly. The statement from the RPC is available at the following link:</p><p><a href="https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc" target="_blank">https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 19768 question first answered 28/03/2024 13:38:15 answering member 4117 label Biography information for Andrea Leadsom previous answer version 26255 answering member constituency South Northamptonshire answering member printed Andrea Leadsom answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1697951

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tobacco and Vapes Bill
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will publish the Regulatory Policy Committee's original opinion on the Tobacco and Vapes Bill submitted to her Department on 12 February 2024; if she will outline the changes she has made to that Bill since receiving that opinion; and what discussions she has had with the Regulatory Policy Committee on the expected timetable for their submission of the revised opinion.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	19768
answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. That is why we have introduced the Tobacco and Vapes Bill to create the first smokefree generation, and enable us to further crack down on youth vaping. The Tobacco and Vapes Bill is available at the following link:</p><p><a href="https://bills.parliament.uk/bills/3703" target="_blank">https://bills.parliament.uk/bills/3703</a></p><p>On 12 February 2024 the Regulatory Policy Committee (RPC) gave opinion on the Tobacco and Vapes Bill impact assessment and rated it green (fit for purpose). However, on 19 March 2024, ahead of the introduction of the bill, a revised version was sent to the RPC for comment. This included changes to reflect the inclusion of Northern Ireland in the bill, following the formation of a Northern Ireland Executive, and a power in the bill to enable the current notification system for nicotine vapes to also cover non-nicotine vapes and other consumer nicotine products, for instance nicotine pouches. The RPC have publicly stated that they welcome the resubmission of the revised impact assessment, and we expect a revised opinion to be issued shortly. The statement from the RPC is available at the following link:</p><p><a href="https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc" target="_blank">https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 19767 question first answered 28/03/2024 13:38:15 answering member 4117 label Biography information for Andrea Leadsom previous answer version 26256 answering member constituency South Northamptonshire answering member printed Andrea Leadsom answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1697032

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure retail food businesses comply with measures in the Food Information Regulations 2014 on providing written allergen information for labels.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	19237
answer	answer is ministerial correction date of answer 25/03/2024 answer text <p>The Food Standards Agency (FSA) is responsible for food safety related labelling, including allergens. Local authorities are responsible for enforcing food law in the vast majority of food businesses, including those in the retail and catering sector. As central competent authority, the FSA monitors the delivery of official controls by local authorities.</p><p>The FSA produces the statutory Food Law Code of Practice and associated Practice Guidance establishing a set of expectations for the activities local authorities are responsible for under food law, and how these are to be delivered. This is supported by a range of training, advice, and guidance to help food officers discharge their functions. Recent changes to the Food Law Code of Practice will enable a more risk-based and intelligence-driven approach to targeting premises for food standards inspections and carrying out interventions, and includes specific consideration of the risk factor for compliance with providing allergen information.</p><p>The FSA also provides support for food businesses, for example through guidance and training, on providing allergen information in line with the requirements of the 2014 Food Information to Consumer Regulations to help drive up compliance and make it easier for people with a food allergy, intolerance, and coeliac disease to make safe choices when eating out.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 25/03/2024 11:12:22 answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1696697

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Skin Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the effectiveness of drugs available within the NHS to treat (a) epidermolysis bullosa and (b) other inflammatory skin conditions.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18966
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes independent, evidence-based recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits.</p><p>Currently, there is one product licensed specifically for epidermolysis bullosa, Filsuvez gel, which contains birch bark extract. The NICE recommends birch bark extract as a clinically and cost effective use of NHS resources, and the NHS is legally required to fund it in line with the NICE’s recommendations. Other healthcare products are also used in the care of epidermolysis bullosa patients. There are a number of licensed and NICE recommended treatments for other inflammatory skin conditions that are now routinely available for NHS patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/03/2024 12:21:44 answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope

1696500

registered interest
date	15/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will (a) publish average weight to height ratios for children in England and (b) provide advice on any health implications for those who have a ratio significantly larger or smaller than the average.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18830
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Child Measurement Programme (NCMP) collects data on the height and weight status of children aged four to five years old, who are in Reception, and 10 to 11 years old, who are in Year six. The data collected and published by NHS England is expressed as a Body Mass Index (BMI) centile, to estimate child overweight and obesity. Data on average weight to height ratios for children in England is not available. The Department does not plan to publish data on average weight to height ratios, or average waist to height ratios for children in England. Waist measurements are not collected as part of the NCMP.</p><p>The clinical guidance from the National Institute of Health and Care Research recommends that a waist to height ratio measurement is considered alongside a child’s BMI centile in individual clinical assessments, to give a practical estimate of central adiposity. If a child falls into an unhealthy weight category, a waist to height ratio will give additional health information in clinical settings. This includes helping to assess and predict individual health risks such as type 2 diabetes, hypertension, or cardiovascular disease, as the location of where children carry weight on their bodies has an influence on their health.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 21/03/2024 13:45:32 answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1696501

registered interest
date	15/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Euthanasia: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact on NHS services of the introduction of legislation to permit assisted dying.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18831
answer	answer is ministerial correction date of answer 27/03/2024 answer text <p>No assessment has been made.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 27/03/2024 10:47:43 answering member 4527 label Biography information for Helen Whately
tabling member	242 label Biography information for Sir Christopher Chope